Investigational Drug Information for ATI-450
✉ Email this page to a colleague
What is the drug development status for ATI-450?
ATI-450 is an investigational drug.
There have been 7 clinical trials for ATI-450.
The most recent clinical trial was a Phase 2 trial, which was initiated on March 16th 2020.
The most common disease conditions in clinical trials are Arthritis, Breast Neoplasms, and Syndrome. The leading clinical trial sponsors are Aclaris Therapeutics, Inc., United States Department of Defense, and Washington University School of Medicine.
Summary for ATI-450
US Patents | 0 |
International Patents | 23 |
US Patent Applications | 7 |
WIPO Patent Applications | 6 |
Japanese Patent Applications | 2 |
Clinical Trial Progress | Phase 2 (2020-03-16) |
Vendors | 11 |
Recent Clinical Trials for ATI-450
Title | Sponsor | Phase |
---|---|---|
Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic Arthritis | Aclaris Therapeutics, Inc. | Phase 2 |
ATI-450 Plus MTX Versus Placebo Plus MTX in Patients With Moderate to Severe Active RA | Aclaris Therapeutics, Inc. | Phase 2 |
ATI-450 vs Placebo in Patients With Moderate to Severe Hidradenitis Suppurativa (HS) | Aclaris Therapeutics, Inc. | Phase 2 |
Clinical Trial Summary for ATI-450
Top disease conditions for ATI-450
Top clinical trial sponsors for ATI-450
US Patents for ATI-450
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for ATI-450
Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
---|---|---|---|---|
ATI-450 | Canada | CA2917344 | 2033-06-07 | ⤷ Try a Trial |
ATI-450 | China | CN105263326 | 2033-06-07 | ⤷ Try a Trial |
ATI-450 | China | CN108478579 | 2033-06-07 | ⤷ Try a Trial |
ATI-450 | Denmark | DK3003039 | 2033-06-07 | ⤷ Try a Trial |
>Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |